Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on October 23, 2026

4 hours ago

Gene Synthesis: Technologies and Global Markets to Reach $7.2 Billion by 2031

Indeterminate GlobeNewswire

4 hours ago

ImPact Biotech Reports Encouraging Early Clinical Results From Phase 1 Study of Padeliporfin VTP in Pancreatic Cancer, with Seven Previously Unresectable Patients Undergoing Surgical Resection Following Treatment

Indeterminate GlobeNewswire

4 hours ago

Humacyte at ASN Kidney Week: Phase 3 Trial Built for Women Shows ATEV Advantage Over Fistula, Getting Patients Off Catheters Months Sooner

Indeterminate GlobeNewswire

4 hours ago

Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026

Indeterminate GlobeNewswire

4 hours ago

Avacta Highlights pre|CISION® Platform Data and Ongoing FOCUS-01 Trial Design with FAP-Exd (AVA6103)

Indeterminate GlobeNewswire

4 hours ago

Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026

Indeterminate GlobeNewswire

4 hours ago

BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer

Indeterminate GlobeNewswire

5 hours ago

Super Vision Technology: World’s first i-NYS implant for congenital nystagmus in a Chinese boy

Indeterminate GlobeNewswire

5 hours ago

Treace to Report Third Quarter 2026 Financial Results on November 6, 2026

Indeterminate GlobeNewswire

5 hours ago

KFSH Marks Four Decades of Cardiac Innovation, from One Cath Lab to an Integrated Heart Center

Indeterminate GlobeNewswire

5 hours ago

Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials

Indeterminate GlobeNewswire

5 hours ago

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

Indeterminate GlobeNewswire

5 hours ago

Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy

Indeterminate GlobeNewswire

6 hours ago

Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3

Indeterminate GlobeNewswire

6 hours ago

Stephanie Mills to Headline 2026 Pennsylvania Maternal Health Summit, Bringing National Attention to Maternal and Infant Health

Indeterminate GlobeNewswire

8 hours ago

Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA

Indeterminate GlobeNewswire

8 hours ago

Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer

Indeterminate GlobeNewswire

9 hours ago

ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial

Indeterminate GlobeNewswire

9 hours ago

ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

9 hours ago

KFSH Cuts the Wait for an Echocardiography Appointment from 126 Days to One

Indeterminate GlobeNewswire